The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection—suramin inhibits EV71 infection in vitro and in vivo

Cell Surface Vimentin Is an Attachment Receptor for Enterovirus 71

(2014) N. Du et al.   JOURNAL OF VIROLOGY

Hand, foot, and mouth disease in China, 2008–12: an epidemiological study

(2014) Weijia Xing et al.   LANCET INFECTIOUS DISEASES

Molecular Comparison and Evolutionary Analyses of VP1 Nucleotide Sequences of New African Human Enterovirus 71 Isolates Reveal a Wide Genetic Diversity

(2014) Maël Bessaud et al.   PLoS One

Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: Evaluation of antiviral efficacy in a murine infection model

(2013) Xiaonan Zhang et al.   ANTIVIRAL RESEARCH

Functional Comparison of SCARB2 and PSGL1 as Receptors for Enterovirus 71

(2013) S. Yamayoshi et al.   JOURNAL OF VIROLOGY

Study of the Integrated Immune Response Induced by an Inactivated EV71 Vaccine

(2013) Longding Liu et al.   PLoS One

Structure of human enterovirus 71 in complex with a capsid-binding inhibitor

(2013) P. Plevka et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Children of rural-to-urban migrant workers in China are at a higher risk of contracting severe hand, foot and mouth disease and EV71 infection: a hospital-based study

(2013) Mei Zeng et al.   Emerging Microbes & Infections

In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection

(2012) Guofeng Zhang et al.   ARCHIVES OF VIROLOGY

Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes

(2012) Maryam B. Lustberg et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Blocking HCV entry as potential antiviral therapy

(2012) Koen Vercauteren et al.   Future Virology

Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai

(2012) Mei Zeng et al.   JOURNAL OF CLINICAL VIROLOGY

Design, Synthesis, and Antiviral Activity of Entry Inhibitors That Target the CD4-Binding Site of HIV-1

(2012) Francesca Curreli et al.   JOURNAL OF MEDICINAL CHEMISTRY

Enterovirus 71 Uses Cell Surface Heparan Sulfate Glycosaminoglycan as an Attachment Receptor

(2012) C. W. Tan et al.   JOURNAL OF VIROLOGY

Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications

(2012) Wei Xu et al.   Virology Journal

In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71

(2012) Hamid Reza Pourianfar et al.   VIRUS RESEARCH

Protein Binding: Do We Ever Learn?

(2011) Markus A. Zeitlinger et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Enterovirus 71 and Coxsackievirus A16 3C Proteases: Binding to Rupintrivir and Their Substrates and Anti-Hand, Foot, and Mouth Disease Virus Drug Design

(2011) G. Lu et al.   JOURNAL OF VIROLOGY

Pathogenesis study of enterovirus 71 infection in rhesus monkeys

(2011) Ying Zhang et al.   LABORATORY INVESTIGATION

Antiparasitic Therapy

(2011) Shanthi Kappagoda et al.   MAYO CLINIC PROCEEDINGS

Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection

(2011) Longding Liu et al.   VIROLOGY

Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication

(2011) Jiangning Liu et al.   Virology Journal

Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer

(2010) Elaine T. Lam et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Phylogenetic evidence for a recent spread of two populations of human enterovirus 71 in European countries

(2010) A. Mirand et al.   JOURNAL OF GENERAL VIROLOGY

Virology, epidemiology, pathogenesis, and control of enterovirus 71

(2010) Tom Solomon et al.   LANCET INFECTIOUS DISEASES

Clinical features, diagnosis, and management of enterovirus 71

(2010) Mong How Ooi et al.   LANCET NEUROLOGY

Enterovirus 71: epidemiology, pathogenesis and management

(2009) Shih-Min Wang et al.   Expert Review of Anti-Infective Therapy

Enterovirus 71 Outbreak in the People's Republic of China in 2008

(2009) F. Yang et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Scavenger receptor B2 is a cellular receptor for enterovirus 71

(2009) Seiya Yamayoshi et al.   NATURE MEDICINE

Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71

(2009) Yorihiro Nishimura et al.   NATURE MEDICINE

Avian Influenza H5-Containing Virus-Like Particles (VLPs): Host-Cell Receptor Specificity by STD NMR Spectroscopy

(2008) Thomas Haselhorst et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity

(2008) M. Arita et al.   JOURNAL OF GENERAL VIROLOGY

Selective inhibitors of picornavirus replication

(2008) Armando M. De Palma et al.   MEDICINAL RESEARCH REVIEWS

Sialic acid dependence in rotavirus host cell invasion

(2008) Thomas Haselhorst et al.   Nature Chemical Biology